Zhejiang Tianyu Pharmaceutical Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 77.9%

Zhejiang Tianyu Pharmaceutical Co Ltd strategic asset allocation index. Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Strategic Asset Allocation Index of 77.9% as of June 2023. Strategic assets (PP&E of CN¥2.78 Billion plus long-term investments of CN¥-) total CN¥2.78 Billion, measured against net assets of CN¥3.57 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Zhejiang Tianyu Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

SAAI

77.9%
Strategic Assets / Net Assets

Strategic Assets

CN¥2.78 Billion
PP&E + LT Investments

PP&E

CN¥2.78 Billion
CNY

Net Assets

CN¥3.57 Billion
CNY

Strategic Asset Allocation Index of Zhejiang Tianyu Pharmaceutical Co Ltd (2016–2022)

Strategic asset allocation index of Zhejiang Tianyu Pharmaceutical Co Ltd from 2016 to 2022. This chart shows how Zhejiang Tianyu Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 77.9%, representing strategic assets of CN¥2.78 Billion against net assets of CN¥3.57 Billion CNY. Check tangible net worth ratio of Zhejiang Tianyu Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.

Zhejiang Tianyu Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2016–2022)

Zhejiang Tianyu Pharmaceutical Co Ltd strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Tianyu Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Zhejiang Tianyu Pharmaceutical Co Ltd.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 80.4% CN¥2.81 Billion CN¥2.81 Billion CN¥- CN¥3.50 Billion ▲ +13.9 pp
2021 66.5% CN¥2.46 Billion CN¥2.46 Billion CN¥- CN¥3.71 Billion ▲ +19.6 pp
2020 46.9% CN¥1.66 Billion CN¥1.66 Billion CN¥- CN¥3.55 Billion ▼ -10.9 pp
2019 57.8% CN¥1.18 Billion CN¥1.18 Billion CN¥- CN¥2.04 Billion ▼ -2.1 pp
2018 59.9% CN¥866.13 Million CN¥866.13 Million CN¥- CN¥1.45 Billion ▲ +7.3 pp
2017 52.6% CN¥677.19 Million CN¥677.19 Million CN¥- CN¥1.29 Billion ▼ -45.9 pp
2016 98.5% CN¥597.98 Million CN¥597.98 Million CN¥- CN¥607.31 Million —
pp = percentage points